Philips program developing AI-powered ultrasound to expand access to maternal health receives major funding boost

November 7, 2023

  • Total investment from the Bill & Melinda Gates Foundation reaches USD 60 million, accelerating expansion of new AI-guided ultrasound capabilities on Philips Lumify Handheld Ultrasound
  • Innovation helps address worldwide shortage of healthcare workers by putting diagnostic tool previously reserved for expert technicians in the hands of midwives

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received a second round of funding from the Bill & Melinda Gates Foundation to accelerate global adoption of AI algorithms on Philips Lumify Handheld Ultrasound. By using AI to simplify key measurements to identify abnormalities during pregnancy, training time to use the ultrasound system can be reduced from weeks to just hours, hugely expanding the pool of frontline health workers who can learn to use the technology and integrate it into routine care.

Results since the Bill & Melinda Gates Foundation provided its first phase of grant funding in 2021 have shown a positive impact in Kenya where the technology has helped drive better-informed decision-making when triaging pregnant women in rural underserved communities. The new phase of funding will support the deployment of the AI-assisted tool to underserved communities globally.

Each day, nearly 800 women around the world die from preventable causes related to pregnancy and childbirth [1], with nearly 95% of all maternal deaths occurring in low- and lower-middle-income countries in 2020. Care provided by skilled health professionals before, during and after childbirth can help save the lives of women and newborns worldwide [1].

New AI-guided algorithms assist in risk-based triaging
The World Health Organization recommends at least one ultrasound scan before 24 weeks of gestation for pregnant women to evaluate gestational age and improve detection of fetal abnormalities with greater confidence [2]. With this latest development, Philips Lumify Handheld Ultrasound will be the first point-of-care ultrasound (POCUS) device to be introduced commercially to assist non-expert users by automating image acquisition or image interpretation for a comprehensive set of obstetrics measurements, increasing quality access to early fetal ultrasound scans.

“Ultrasound is the first tool of choice to scan pregnant women, but it also requires training to understand how to scan properly and correctly in order to make the right image interpretations,” said Jeff Cohen, General Manager of Ultrasound at Philips. “By supporting front-line healthcare workers such as midwives to identify potential problems in pregnancy at an early stage, we aim to significantly reduce the number of women who die because of pregnancy. During this next phase, working with the Bill & Melinda Gates Foundation, we will bring this innovation as a commercial offering to the market to help increase quality access to care and improve maternal health in underserved and rural communities in developed and developing countries worldwide.”

“One of our key areas of focus is to build partnerships that bring together resources, expertise, and vision – working with organizations around the world to identify issues, find answers, and drive change,” said Dr. Rasa Izadnegahdar, Director, Maternal, Newborn and Child Health Discovery & Tools at the Bill & Melinda Gates Foundation. “A critical goal of our work at the Bill & Melinda Gates Foundation is to bring health technology to underserved areas of the world to help prevent women from dying in childbirth – an issue that is critical in high-income countries like the US and UK as well.”

Prototype results show increased confidence for midwives
During a trial period in Kenya, feedback on the new tool has shown positive impact. Thanks to digitalization, informatics, and AI, interpretation of the images is not required by the operator. Weeks of training for midwives have been reduced to hours, without negatively affecting confidence in triage. Expectant moms also find it comforting to know how their baby is progressing. Depending on the results, patients can be referred to a credentialed sonographer for image review and further investigation if needed.

“With this disruptive technology, we are introducing a new way of ultrasound scanning where midwives and non-expert users are guided by the algorithm to give them access to critical information they need most when triaging pregnant women in underserved areas, and rural settings,” said Matthijs Groot Wassink, General Manager for Point of Care and Obstetric Ultrasound at Philips. “The prototype identifies six critical parameters for high-risk assessments to help improve the health of both mom and baby, such as gestational age and placenta location. With the automated AI capabilities built into Philips Lumify, frontline workers can identify abnormalities earlier, helping to increase confidence and comfort of the mother in any decisions or care pathways she decides to pursue or not.”

Philips’ leadership in Ultrasound worldwide
Philips Ultrasound systems installed around the world perform an estimated 1.33 billion diagnostic and interventional procedures each year. With this latest AI-enabled POCUS prototype, Philips continues its commitment to deliver industry-first innovations in areas such as 3D imaging of the heart, AI-powered quantification tools, and ultra-mobile portable ultrasound solutions. Visit Philips Ultrasound for more information on the latest innovations in cardiology, general imaging and point-of-care OB/GYN ultrasound solutions.

More information on the program can be found in this FAQ.


For further information, please contact:

Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978 221 8919

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 71,500 employees with sales and services in more than 100 countries. News about Philips can be found at


Primary Logo

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.